Breaking Finance News

finnCap announced LiDCO Group PLC (LON:LID), maintaining its target price at 14.00GBX today

Having a price of 7.00GBX, LiDCO Group PLC (LON:LID) traded -1.71% lower on the day. With the last stock price close up 2.22% from the two hundred day average, compared with the S&P 500 Index which has decreased -0.03% over the date range. LiDCO Group PLC has recorded a 50-day average of 6.94GBX and a two hundred day average of 6.73GBX. Volume of trade was down over the average, with 2,873 shares of LID changing hands under the typical 207,131

LiDCO Group PLC (LON:LID) had its target price hold steady to 14.00GBX by finnCap in an issued report issued 11/29/2016. The updated price target implies a potential upside of 1% from the company's previous stock price.

Performance Chart

LiDCO Group PLC (LON:LID)

With a total market value of 0 GBX, LiDCO Group PLC has with a one year low of 5.25GBX and a one year high of 9.25GBX .

A total of 1 equity analyst has released a ratings update on LID. zero analysts rating the company a strong buy, zero analysts rating the company a buy, zero analysts rating the company a hold, zero analysts rating the company a underperform, and finally zero analysts rating the company a sell with a 12-month price target of 14.00GBX.

More About LiDCO Group PLC (LON:LID)

LiDCO Group Plc is a United Kingdom-based supplier of non-invasive and minimally invasive hemodynamic monitoring equipment to hospitals. The Company is engaged in the development, manufacture and sale of cardiac monitoring equipment. It operates in the segment of supply of monitors, consumables and support services associated with the use of its cardiac monitoring equipment. The Company's products include LiDCOplus, a computer-based platform monitor; LiDCOrapid, a cardiac output monitor; LiDCOview, a graphical display, and LiDCOunity, which is its hemodynamic monitor. Its LiDCOrapid is designed for multi-parameter monitoring of both depth of anesthesia and fluids. Its products are used in the treatment of high-risk patients in both critical care units and in the operating theatre. They monitor the amount of blood flowing around the body helping clinicians and nurses to ensure that organs are kept perfused with oxygenated blood by the adjustment of supportive fluid and drugs.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *